KeyBanc Raises Price Target for Progyny (NASDAQ:PGNY) Amid Strong Buy Rating

• KeyBanc maintained an "Overweight" rating for Progyny and raised its price target to $35.00 from $30.00.
• Progyny received a Zacks Rank #1 (Strong Buy), driven by positive earnings estimate revisions.
• The stock exhibits strong momentum, evidenced by a Zacks Momentum Style Score of A.

Progyny (NASDAQ:PGNY), a leading provider of fertility and family-building benefits to employers, recently received a positive endorsement. On July 13, 2026, the analyst firm KeyBanc confirmed its optimistic view on the company's investment outlook. KeyBanc maintained an "Overweight" rating for Progyny, signaling a belief that the stock performance will surpass the market average.

KeyBanc further demonstrated its confidence by raising its price target for the stock to $35.00, an increase from the previous target of $30.00. A price target represents an analyst's projection of a stock's future valuation. At the time of the report, Progyny's stock was trading at $30.65, suggesting significant potential for growth based on this updated target.

This optimistic investment outlook is further supported by independent analyses. As highlighted by Zacks Investment Research, Progyny has been upgraded to a Zacks Rank #1 (Strong Buy). This significant upgrade is primarily attributed to a positive trend in earnings estimate revisions, which reflect analysts' improved predictions of the company's future profitability.

The increasing confidence in Progyny's financial future is a recurring theme among analysts. Experts are reportedly becoming more optimistic about Progyny's earnings prospects. Zacks Investment Research emphasizes the strong correlation between positive changes in earnings estimates and a stock's near-term price movement, reinforcing the bullish sentiment.

Progyny's stock momentum and recent trading activity also indicate strength. The company holds a Zacks Momentum Style Score of A, a key indicator for investors seeking stocks with recent upward price trends. Over the past year, Progyny has traded within a trading range between a low of $16.10 and a high of $31.36.